Impact of
BCR
PET
change in management
impact
molecular imaging
prostate cancer
Journal
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
13
01
2020
accepted:
07
04
2020
pubmed:
3
5
2020
medline:
6
3
2021
entrez:
3
5
2020
Statut:
ppublish
Résumé
Prostate-specific membrane antigen (PSMA) ligand PET induces management changes in patients with prostate cancer. We aim to better characterize the impact of
Identifiants
pubmed: 32358094
pii: jnumed.120.242180
doi: 10.2967/jnumed.120.242180
pmc: PMC9364898
doi:
Substances chimiques
Gallium Isotopes
0
Gallium Radioisotopes
0
Oligopeptides
0
gallium 68 PSMA-11
0
Edetic Acid
9G34HU7RV0
Types de publication
Clinical Trial
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1793-1799Subventions
Organisme : NCI NIH HHS
ID : R01 CA212148
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016042
Pays : United States
Informations de copyright
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.
Références
BJU Int. 2018 Nov;122(5):783-793
pubmed: 29726071
Eur Urol. 2017 Apr;71(4):630-642
pubmed: 27591931
J Nucl Med. 2015 Aug;56(8):1185-90
pubmed: 26112024
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1014-1024
pubmed: 28283702
Lancet Oncol. 2019 Sep;20(9):1286-1294
pubmed: 31375469
J Clin Oncol. 2008 May 1;26(13):2155-61
pubmed: 18362365
Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):889-900
pubmed: 30488099
J Nucl Med. 2018 Mar;59(3):434-441
pubmed: 29242398
Eur Urol. 2020 Apr;77(4):403-417
pubmed: 30773328
J Nucl Med. 2017 Dec;58(12):1956-1961
pubmed: 28522741
J Nucl Med. 2008 Dec;49(12):1928-35
pubmed: 18997054
J Nucl Med. 2018 Mar;59(3):469-478
pubmed: 29123012
Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2114-2121
pubmed: 27290607
Eur Urol Focus. 2018 Sep;4(5):686-693
pubmed: 28753806
JAMA Oncol. 2019 Jun 01;5(6):856-863
pubmed: 30920593
J Nucl Med. 2018 Jan;59(1):82-88
pubmed: 28646014
BMC Cancer. 2019 Jan 7;19(1):18
pubmed: 30616601
Eur Urol. 2018 Aug;74(2):179-190
pubmed: 29678358
JAMA. 1999 May 5;281(17):1591-7
pubmed: 10235151
Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1258-1268
pubmed: 28497198
J Natl Compr Canc Netw. 2019 May 1;17(5):479-505
pubmed: 31085757
J Nucl Med. 2015 May;56(5):668-74
pubmed: 25791990